Achieving innovation by challenging the current process of drug development and disrupting the status quo.

“Tools4Patient is aligned with sponsor companies and CROs in our objective to bring new therapies to market. We aim to consider each patient that participates in clinical trials as an individual and understand how their unique characteristics influence their response to therapy.”
Dominique Demolle, PhD, CEO of Tools4Patient

Innovation Journey Infographics

Tools4Patient is passionate about empowering pharmaceutical and biotech companies to improve decision making and de-risk clinical drug development, ultimately aiming to accelerate patient access to new medications.

The company was founded by long-time colleagues with decades of experience in the pharmaceutical industry who set out to tackle some of the most challenging issues that prevent drugs from reaching the marketplace.

The needs of patients as stakeholders in the therapeutic development process are at the center of Tools4Patient's objective and approach to developing predictive tools.


VP, Business Development

Board of Directors


Scientific Board

Tools4Patient Milestones


Corporate Culture

Our corporate culture is central to the success of our employees, team and company

T4P icons performance

Performance Management

Annual objective setting and performance evaluation aimed to support and develop all employees

T4P icons education

Continuing Education

An opportunity for everyone to learn and stay current in their field of expertise

T4P icons break space

Break space

Dedicated space to promote social interactions,  well-being and relaxation

T4P icons team

Team events

Sports, recreation and social events with colleagues

T4P icons training

Training Program

Each employee is supported by an in-depth training program from day one

T4P icons human

Human Dimension

Management focus on information transparency, individual accountability and growth



Reducing clinical data variability. Empowering better decision making. Accelerating the launch of therapeutics to market.